Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06700109 · ClinicalTrials.gov registry record · NA
Injectable Cold Energy Therapy FOR THE Management OF Chronic Pain Associated With Osteoarthritis OF THE Knee
A NA study of Osteoarthritis (OA) of the Knee, sponsored by Brixton Biosciences.
- Active
- Registry status
- NA
- Development phase
- 263
- Enrollment target
- 15
- Study locations
NCT06700109: Active NA study of Osteoarthritis (OA) of the Knee, sponsored by Brixton Biosciences.
NCT06700109 is a NA study of Osteoarthritis (OA) of the Knee that is active but no longer recruiting, run by Brixton Biosciences. The registered enrollment target is 263 participants, below the 1,381-participant average among 8 other Osteoarthritis (OA) of the Knee trials with a reported enrollment target (81% lower). The trial reports 15 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06700109, a NA study of Osteoarthritis (OA) of the Knee, is active but no longer recruiting, sponsored by Brixton Biosciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 263 participants
- Enrollment target
- 15
- Study locations
Study Summary
The goal of this clinical trial is to evaluate the effectiveness of Neural Ice for pain management associated with knee osteoarthritis in adults aged 22-80 years. Participants will attend study visits and complete subject diaries. Participants will be followed for 6 months after study procedure.
Primary Outcome
The proportion of subjects whose knee pain following activity (Timed Up and Go test) is reduced by ≥30% based on the NRS scale at 3 months post treatment.
Conditions Studied
Interventions
- DEVICE Neural Ice
- DRUG Triamcinolone acetate
Study Locations (15)
Oklahoma
- Clinical Investigations, LLC - Edmond
- NextStage Clinical Research The Orthopedic Center - Tulsa
Texas
- NextStage Clinical Research All-American Orthopedic & Sports Medicine Institute - Houston
- UT San Antonio - San Antonio
California
- Marin Health - Larkspur
District of Columbia
- Centers for Advanced Orthopedics - Washington D.C.
Florida
- The Orthopaedic Institute - Gainesville
Georgia
- Emory University - Johns Creek
Illinois
- Insight Hospital and Medical Center Chicago - Chicago
Kansas
- NextStage Clinical Research Advanced Orthopaedic Associates - Wichita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2024-11-19 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
What the registry record for NCT06700109 still lists
NCT06700109 is an interventional study that assigns participants to a tested intervention. The registered 263 participants enrollment target is mid-sized for trials with a published cap, below the 1,381-participant average among 8 other Osteoarthritis (OA) of the Knee trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Osteoarthritis (OA) of the Knee appearing as the primary indexed condition, and to 2 interventions - of which Neural Ice is the first listed.
NCT06700109 lists 15 locations in 13 states (Oklahoma, Texas, California).
Frequently Asked Questions
What is clinical trial NCT06700109 about?
NCT06700109 is a clinical study titled "Injectable Cold Energy Therapy FOR THE Management OF Chronic Pain Associated With Osteoarthritis OF THE Knee". The goal of this clinical trial is to evaluate the effectiveness of Neural Ice for pain management associated with knee osteoarthritis in adults aged 22-80 years. Participants will attend study visits and complete subject diaries. Participants will be followed for 6 months after study procedure.
What is the current status of trial NCT06700109?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 263 participants. The study started on 2024-11-19. Estimated completion is 2027-02-01.
What conditions does trial NCT06700109 study?
This clinical trial studies the following conditions: Osteoarthritis (OA) of the Knee.
What interventions are being tested in trial NCT06700109?
The interventions under investigation include: Neural Ice (DEVICE), Triamcinolone acetate (DRUG).
Who is sponsoring clinical trial NCT06700109?
This trial is sponsored by Brixton Biosciences, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06700109 being conducted?
This trial has 15 study locations across California, District of Columbia, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis (OA) of the Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06700109's enrollment target sits among peer trials
263 3rd of 8 higher than 6 of 8 other Osteoarthritis (OA) of the Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis (OA) of the Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Platelet Rich Plasma for Musculoskeletal Conditions
RECRUITING · NA
-
Native Alignment in the Setting of an Arthritic Knee in Total Knee Arthroplasty
RECRUITING · NA
-
Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy
RECRUITING · NA
-
Photographic Evidence on Total Knee Arthroplasty Outcomes
COMPLETED · NA
-
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
RECRUITING · Phase 2
-
Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04067336 · 263 participants · Phase 1
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
- NCT06234423 · 263 participants · Phase 1
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- NCT06724627 · 263 participants · NA
Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI